Join to View Full Profile
9500 Euclid AveCleveland, OH 44195
Phone+1 216-444-2200
Are you Dr. Fernandez?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Anthony Fernandez, MD is a board certified dermatologist in Cleveland, Ohio. He is currently licensed to practice medicine in Ohio and Florida.
Education & Training
Cleveland Clinic FoundationFellowship, Dermatopathology, 2011
University of Miami/Jackson Health SystemResidency, Dermatology, 2006 - 2009
Loyola University Medical CenterInternship, Internal Medicine, 2005 - 2006
University of Illinois College of MedicineClass of 2005
Certifications & Licensure
FL State Medical License 2023 - 2027
OH State Medical License 2009 - 2027
American Board of Dermatology Dermatology- American Board of Dermatology Dermatopathology
Publications & Presentations
PubMed
- Histopathologic Features of Acral Skin Biopsies in Dermatomyositis Patients and Comparison to Histopathologic Features in Non-Acral Biopsies.Lydia Cassard, Firdous Ali, Elizabeth M Flatley, Anthony Patrick Fernandez
Journal of Cutaneous Pathology. 2025-04-01 - 1 citationsIdiopathic inflammatory myopathies related lung disease in adults.Sameep Sehgal, Aditi Patel, Soumya Chatterjee, Anthony P Fernandez, Carol Farver
The Lancet. Respiratory Medicine. 2025-03-01 - 3 citationsEfficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, p...David Fiorentino, Aaron R Mangold, Victoria P Werth, Lisa Christopher-Stine, Alisa Femia
Lancet. 2025-01-11
Authored Content
- Creation and Validation of Classification Criteria for Discoid Lupus ErythematosusJune 2020
- Creation and Validation of Classification Criteria for Discoid Lupus ErythematosusJune 2020
- Creation and Validation of Classification Criteria for Discoid Lupus ErythematosusJune 2020
- Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil andApril 2020
- Join now to see all
Press Mentions
Anti–IL-23 Therapy Might Emerge as Best Biologic in Psoriasis if Used Early and at High DosesMarch 20th, 2025- Vaccine Hesitancy in the Time of COVID: Part OneJanuary 31st, 2025
- Treatments for Obstructive Sleep Apnea Part TwoMay 1st, 2024
- Join now to see all
